Clinical Trials on Type I Hypersensitivity in Argentina
Total 816 results
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Mexico, United States, Hungary, Italy, Argentina, Australia, Brazil, Canada, Chile, Colombia, Lithuania, Poland, Romania, Russian Federation, South Africa, Turkey, Ukraine
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Korea, Republic of, Poland, United Kingdom, Israel, Russian Federation, Italy, Turkey, Argentina, France, Hungary, Mexico, Canada, Czechia, Finland, Portugal, Romania, Slovakia, South Africa
-
GlaxoSmithKlineNot yet recruitingAsthmaArgentina, United States, Canada, Panama, Greece, France, Poland, Italy, United Kingdom
-
MedImmune LLCCompletedAsthmaUnited States, Canada, Peru, Taiwan, Colombia, Brazil, Panama, Philippines, Argentina, Costa Rica
-
AstraZenecaAmgenRecruitingAsthmaUnited States, Poland, Korea, Republic of, Spain, France, China, United Kingdom, Canada, Netherlands, Argentina, Mexico, Brazil, Hungary, Japan, Philippines, South Africa, Colombia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, France, Germany, Poland, Romania, Russian Federation, Canada, Chile, Korea, Republic of, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedHZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsAsthmaUnited States, Argentina, Korea, Republic of, Netherlands, Philippines, Chile
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Poland, Russian Federation, Belgium, Canada, Chile, France, Germany, Korea, Republic of, Netherlands, Peru, Philippines, South Africa, Sweden, Thailand
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaMexico, Spain, Argentina, Japan, Poland, United States, Turkey, Australia, Brazil, Canada, Chile, Colombia, Hungary, Italy, Lithuania, Russian Federation, South Africa, Ukraine
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Philippines, Canada, Brazil
-
SanofiRegeneron PharmaceuticalsCompletedCold UrticariaUnited States, Argentina, Canada, Germany, Japan
-
Bond Avillion 2 Development LPCompletedAsthmaUnited States, Germany, Ukraine, Serbia, Czechia, Argentina, Slovakia
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, South Africa, Hungary, Turkey, Slovakia, Argentina, Philippines, Mexico, Saudi Arabia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Germany, Poland, Romania, Russian Federation, Ukraine, Canada, Chile, France, Korea, Republic of, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
-
Hospital Italiano de Buenos AiresUniversity of Buenos Aires; National Council of Scientific and Technical Research... and other collaboratorsTerminated
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Germany, Guatemala, Hungary, Latvia, Lithuania, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Belgium, Poland, Latvia, Argentina, Guatemala, Philippines, Slovakia, Czechia, Hungary, Russian Federation, Japan, Bulgaria, Canada
-
MedImmune LLCCompletedAsthmaUnited States, Czech Republic, France, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, United Kingdom, Germany, Philippines, Argentina, Canada, Chile, Japan
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Spain, United States, Turkey, Canada, Hungary, Slovakia, Italy, Argentina, Czech Republic, France, Peru
-
AstraZenecaCompletedAsthmaKorea, Republic of, Peru, Philippines, China, Malaysia, Hungary, Japan, Argentina, Thailand, India, Brazil, Costa Rica
-
AstraZenecaCompletedAsthmaUnited States, Canada, France, Turkey, Korea, Republic of, Argentina, Germany, Poland, Ukraine, Spain, Bulgaria, Chile
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Belgium, South Africa, United States, Russian Federation, France, Slovakia, Spain, Thailand, Czechia, Greece, Argentina, Peru, United Kingdom, Bulgaria, Turkey, Hungary, Vietnam, Philippines, Colombia, Chile
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaArgentina, Dominican Republic, Canada, Brazil, Guatemala, Chile, Mexico, Panama
-
GlaxoSmithKlineCompleted
-
AstraZenecaRecruitingAsthmaDenmark, United States, South Africa, United Kingdom, Argentina, Vietnam, Brazil, Malaysia, Taiwan, France, Germany, Spain, Thailand, Bulgaria, Philippines, Sweden
-
Hoffmann-La RocheCompletedAsthmaKorea, Republic of, United States, Belgium, Czechia, Germany, Peru, Bulgaria, Russian Federation, Argentina, Ukraine, Canada, Poland, South Africa, New Zealand, Romania
-
AstraZenecaCompletedAsthma PatientsUnited States, Mexico, Russian Federation, South Africa, Romania, Ukraine, Japan, Argentina, Slovakia, Brazil
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Mexico, Italy, United Kingdom
-
SanofiActive, not recruitingDose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)AsthmaUnited States, Argentina, Brazil, Canada, Chile, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, South Africa, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedAsthmaGermany, India, Israel, Poland, Argentina, Russian Federation, Greece, Serbia, Turkey, Hungary, Mexico, Peru, Slovakia, Czechia, South Africa, Taiwan, Vietnam, Spain, Colombia, Chile
-
GlaxoSmithKlineCompletedHepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell PertussisArgentina, Nicaragua
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Argentina, Germany, United States
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAllergic Fungal RhinosinusitisChina, Argentina, Israel, United States, Canada, India, Japan, Saudi Arabia, Turkey
-
GlaxoSmithKlineTerminatedMelanomaNorway, Argentina, Greece
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, United Kingdom, Czechia, Mexico, Italy
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaUnited States, Argentina, Belgium, Canada, France, Germany, Israel, Japan, Netherlands, South Africa
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Romania, Russian Federation, Ukraine, Chile, Sweden, Mexico, Netherlands, Poland
-
AstraZenecaAmgenCompletedAsthmaUnited States, Austria, Canada, France, Germany, Taiwan, Vietnam, Korea, Republic of, Brazil, Turkey, Argentina, Australia, Israel, Poland, Russian Federation, Saudi Arabia, South Africa, Ukraine
-
GlaxoSmithKlineCompletedRhinitis, Allergic, PerennialUnited States, Argentina, Slovakia, Finland, Chile, Mexico, Italy
-
Alkermes, Inc.RecruitingSchizophrenia | Bipolar I DisorderUnited States, Argentina, Mexico, Brazil, Colombia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthma | Elevated Blood Eosinophils | Oral Corticosteroid DependenceUnited States, Argentina, Australia, Belgium, Czechia, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Spain, Ukraine
-
Teva Branded Pharmaceutical Products R&D, Inc.PPDCompletedAsthmaUnited States, Argentina, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Russian Federation, South Africa, Spain, Turkey, Ukraine
-
Novartis PharmaceuticalsCompletedAsthmaUnited States, India, Spain, Italy, Israel, Netherlands, Russian Federation, Lebanon, South Africa, Czechia, Greece, Serbia, Argentina, Mexico, Slovakia, Canada, Taiwan, Malaysia, Japan
-
Chiesi Farmaceutici S.p.A.RecruitingUncontrolled AsthmaArgentina, Bulgaria, Czechia, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Poland, Romania, South Africa, Spain
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, United States, Argentina, Canada, Germany, Italy, Netherlands, Portugal, Russian Federation, Ukraine, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, United States, Chile, Australia, France, Mexico, Argentina, Italy, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, Korea, Republic of, New Zealand
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Japan, Chile, Peru, Philippines, Poland, Mexico, Slovakia, Ukraine, South Africa, Puerto Rico, Georgia
-
Genentech, Inc.CompletedAsthmaBelgium, Germany, United States, New Zealand, Canada, Poland, Bulgaria, Romania, Russian Federation, Hungary, Ukraine, Peru, Argentina, Mexico